Patents by Inventor Philip Breitfeld

Philip Breitfeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING HEMATOLOGIC CANCERS
    Publication number: 20240100055
    Abstract: The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.
    Type: Application
    Filed: November 1, 2023
    Publication date: March 28, 2024
    Inventors: Shanta BANTIA, Philip BREITFELD, Yarlagadda S. BABU
  • METHODS OF TREATING HEMATOLOGIC CANCERS
    Publication number: 20220040188
    Abstract: The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.
    Type: Application
    Filed: August 4, 2021
    Publication date: February 10, 2022
    Inventors: Shanta BANTIA, Philip BREITFELD, Yarlagadda S. BABU
  • Methods of treating hematologic cancers
    Patent number: 11110092
    Abstract: The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.
    Type: Grant
    Filed: May 1, 2019
    Date of Patent: September 7, 2021
    Assignee: BIOCRYST PHARMACEUTICALS, INC.
    Inventors: Shanta Bantia, Philip Breitfeld, Yarlagadda S Babu
  • METHODS OF TREATING HEMATOLOGIC CANCERS
    Publication number: 20190255058
    Abstract: The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.
    Type: Application
    Filed: May 1, 2019
    Publication date: August 22, 2019
    Inventors: Shanta Bantia, Philip Breitfeld, Yarlagadda S. Babu
  • METHODS OF TREATING HEMATOLOGIC CANCERS
    Publication number: 20140178372
    Abstract: The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.
    Type: Application
    Filed: February 26, 2014
    Publication date: June 26, 2014
    Applicant: BIOCRYST PHARMACEUTICALS, INC.
    Inventors: Shanta BANTIA, Philip BREITFELD, Yarlagadda S. BABU
  • METHODS OF TREATING HEMATOLOGIC CANCERS USING PNP INHIBITORS SUCH AS FORODESINE IN COMBINATION WITH ALKYLATING AGENTS OR ANTI-CD20 AGENTS
    Publication number: 20110038858
    Abstract: The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.
    Type: Application
    Filed: December 10, 2008
    Publication date: February 17, 2011
    Applicant: Biocryst Pharmaceuticals, Inc.
    Inventors: Shanta Bantia, Philip Breitfeld, Yarlagadda S. Babu